Human body bio-factories of tommorow for organ and tissue replacement.
Ira Pastor, ideaXme life sciences ambassador interviews Dr Alexander Titus Chief Strategy Officer (CSO) at the Advanced Regenerative Manufacturing Institute (ARMI).
Ira Pastor comments:
The Advanced Regenerative Manufacturing Institute (ARMI) is one of 14 institutes of the Manufacturing USA network, and is a member-driven, non-profit organization, whose mission is to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies.
BioFabUSA, created by ARMI, was established to lead the charge in large-scale manufacturing of engineered tissues and regenerative medicine research, turning foundational breakthroughs in the manufacture of engineered tissues and tissue-related technologies into life-changing possibilities for everyone.
Dr. Alexander Titus is the Chief Strategy Officer (CSO) at the Advanced Regenerative Manufacturing Institute (ARMI) where he is part of the leadership team working to advance the U.S. regenerative manufacturing industry, as well as develop technologies for disaster preparedness. Dr. Titus’s career is focused on the intersection of technology and public benefit, with experience spanning the private and public sectors, as well as non-profits and academia.
Prior to his role ARMI, Dr Titus was the inaugural Assistant Director for Biotechnology, within the Office of the CTO at the Department of Defense (DoD), where he was the Deputy Assistant Secretary of Defense-level senior executive in charge of the DoD’s enterprise strategy for biotechnology, where he led the team developing the biotechnology modernization roadmap for the DoD.
Dr. Titus joined the DoD from McKinsey & Company, where he was a management consultant and a member of the inaugural cohort of Defense & Security Specialists working with the national security community on high-priority issues related to organization effectiveness, leadership, and analytics.
Comments are closed.